This study aimed to investigate the relationship of hypertension with beta-amyloid (Aβ) and
neurodegeneration biomarkers of Alzheimer's disease (AD) and the modulating effect of …

Objectives: Amyloid-β (Aβ) deposition in the brain is the hallmark of Alzheimer's disease
(AD) pathology. Hypertension is a risk factor for AD, but the effects of hypertension on Aβ …

Epidemiological evidence suggests that hypertension may accelerate the onset and
progression of Alzheimer′ s disease (AD). In this study, we explored the role of …

BACKGROUND: There is epidemiological evidence that cardiovascular risk factors (CVRF)
also are risk factors for Alzheimer's disease, but there is limited information on this from …

We examined the impact of hypertension on cerebrospinal fluid (CSF) biomarkers amyloid-
β1− 42 (Aβ42), total tau (tau), and phosphorylated tau at threonine 181 (ptau-181), and …

Background and purpose A growing body of evidence suggests that cardiovascular disease
risk factors including hypertension may be linked to sporadic Alzheimer's disease (AD). It is …

Epidemiological studies suggest that elevated blood pressure (BP) in midlife is associated
with increased risk of Alzheimer's disease (AD) in late life. In this preliminary study, we …

Background Hypertension has been associated with Alzheimer's disease (AD) dementia as
well as vascular dementia. However, the underlying neuropathological changes that link …

Abstract Background: Cardiovascular disease (CVD), including elevated blood pressure
(BP), is known to promote Alzheimer's disease (AD) risk. Although brain amyloid load is a …

Epidemiological data associate hypertension with a predisposition to Alzheimer's disease
(AD), and a number of postmortem and in vivo studies also demonstrate that hypertension …